These experimental findings are in line with the clinical observation that TRAIL circulating levels not only are decreased in T1DM patients but also are negatively correlated with patient insulin requirement, and the lowest levels of TRAIL are observed in those patients with diabetic ketoacidosis at onset [68]. Here, TNFSF10 is linked to diabetic ketoacidosis.